Division of Neurosurgery, Department of Surgery, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
Neurosurg Focus. 2012 Jan;32(1):E3. doi: 10.3171/2011.10.FOCUS11252.
Recent advances in molecular neurooncology provide unique opportunities for targeted molecular-based therapies. However, the blood-brain barrier (BBB) remains a major limitation to the delivery of tumor-specific therapies directed against aberrant signaling pathways in brain tumors. Given the dismal prognosis of patients with malignant brain tumors, novel strategies that overcome the intrinsic limitations of the BBB are therefore highly desirable. Focused ultrasound BBB disruption is emerging as a novel strategy for enhanced delivery of therapeutic agents into the brain via focal, reversible, and safe BBB disruption. This review examines the potential role and implications of focused ultrasound in molecular neurooncology.
分子神经肿瘤学的最新进展为靶向分子治疗提供了独特的机会。然而,血脑屏障(BBB)仍然是针对脑肿瘤中异常信号通路的肿瘤特异性治疗药物递送的主要限制。鉴于恶性脑肿瘤患者的预后不佳,因此非常需要克服 BBB 固有局限性的新型策略。聚焦超声 BBB 破坏正在成为一种通过局灶性、可逆和安全的 BBB 破坏将治疗剂递送到大脑中的新策略。本文综述了聚焦超声在分子神经肿瘤学中的潜在作用和意义。